Background: Sialic acid-binding immunoglobulin-like lectin 8 () is involved in the progression of numerous diseases. This study aimed to examine the relationship between and the prognosis of patients with low-grade glioma (LGG) and the related mechanisms.
Methods: First, screening of the differentially expressed genes (DEGs) in The Cancer Genome Atlas (TCGA) database was performed. The expression was then correlated with the prognosis of patients with LGG and then verified using the Tumor Immune Estimation Resource (TIMER) and TCGA databases. Cox regression was employed to conduct multifactorial analysis and was followed by the construction of an internally validated nomogram based on these results. To investigate the possible mechanisms, we used gene set enrichment analysis (GSEA). We conducted a retrospective analysis of the clinical information of patients with LGG who were treated at Longgang Central Hospital of Shenzhen from January 2018 to December 2020 and from whom tumor and peritumoral tissues were taken during surgery. Expression of essential genes was identified by employing quantitative real-time polymerase chain reaction (qRT-PCR). Multivariate analysis, via Cox regression, was employed to determine the prognostic factors for patients with LGG.
Results: The transcriptional activity of was found to be elevated in LGG neoplastic tissues compared to neighboring nonneoplastic tissues. Overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI) were improved in patients with LGG with reduced expression of as compared to those with increased expression of . The nomogram's C-index is 0.804 (0.781-0.827). indicating good predictive accuracy. GSEA revealed that might influence LGG biological events by participating in the PD-1, IL3, JAK/STAT, and PI3KCI signal transduction pathways, as well as cytokine and inflammatory response, cell cycle, homeostasis, and extracellular matrix. This study included 72 patients with LGG. qRT-PCR showed upregulated expression in LGG tumor tissues, which was significantly associated with tumor number and metastasis to the lymph nodes (P<0.05). Multivariate analysis using Cox regression identified the high expression of as an independent risk factor in LGG prognosis (P<0.05).
Conclusions: For the prognosis of patients with LGG, the transcriptional activity of is increased in LGG tissues and is an independent risk factor. Interference with could promote tumor progression by regulating the JAK/STAT signaling pathway, indicating that may function as a distinctive predictive biomarker for patients with LGG.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543039 | PMC |
http://dx.doi.org/10.21037/tcr-24-1662 | DOI Listing |
Future Oncol
January 2025
Lou & Jean Malnati Brain Tumor Institute, Northwestern University, Chicago, IL, USA.
Seizures are a frequent complication in glioma. Incidence of brain tumor-related epilepsy (BTRE) in high-grade glioma (HGG) is an estimated > 25% and in low-grade glioma (LGG) is approximately 72%. Two first-line antiseizure medications (ASMs) for BTRE include levetiracetam (LEV) and valproic acid (VPA).
View Article and Find Full Text PDFCurr Neurol Neurosci Rep
January 2025
Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, 80 Avenue Augustin Fliche, Montpellier, 34295, France.
Purpose Of Review: In low-grade glioma (LGG), besides the patient's neurological status and tumor characteristics on neuroimaging, current treatment guidelines mainly rely on the glioma's genetics at diagnosis to define therapeutic strategy, usually starting with surgical resection. However, this snapshot in time does not take into account the antecedent period of tumor progression and its interactions with the brain before presentation. This article reviews new concepts that pertain to reconstruct the history of previous interplay between the LGG's course and adaptive changes in the connectome within which the glioma is embedded over the years preceding the diagnosis.
View Article and Find Full Text PDFSci Rep
January 2025
Nuclear Medicine Department, Medical University of Warsaw, Banacha 1a, 02-097, Warsaw, Poland.
PET/CT targeting prostate-specific membrane antigen (PSMA) is commonly used in patients with prostate cancer. PSMA has been found in other solid tumours, including primary brain tumours. The aim of this study was to evaluate the usefulness of [Ga]Ga-PSMA-11 PET/CT for preoperative diagnosis and 2-year prognosis.
View Article and Find Full Text PDFJ Natl Cancer Cent
December 2024
Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Background: S100A8 is a member of the S100 protein family and plays a pivotal role in regulating inflammation and tumor progression. This study aimed to comprehensively assess the expression patterns and functional roles of S100A8 in glioma progression.
Methods: Glioma tissues were collected from 98 patients who underwent surgical treatment at Fudan University Shanghai Cancer Center.
Mol Neurobiol
December 2024
Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Virus encephalitis (VE), recognized as one of the common kinds of central nervous system (CNS) diseases after virus infection, has a surprising correlation with autoimmune encephalitis (AE) when autoimmune antibodies emerge in cerebrospinal fluid (CSF) or serum. Herpes simplex virus and Epstein-Barr virus are the most critical agents worldwide. By molecular mimicry, herpes viruses can invade the brain directly or indirectly.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!